Showing results (41-50 of 60) with videos related to
Sort By:
Pageof 6
Cancer|August 27, 2004
Free circulating soluble CD52 as a tumor marker in chronic lymphocytic leukemia and its implication in therapy with anti-CD52 antibodiesMaher Albitar, Kim-Anh Do, Marcella M Johnson, et al.The Journal of Clinical Endocrinology and Metabolism|December 31, 2010
Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicatorsMontserrat Ayala-Ramirez, Lei Feng, Marcella M Johnson, et al.British Journal of Haematology|February 13, 2003
Plasma interleukin 8 level predicts for survival in chronic lymphocytic leukaemiaWilliam G Wierda, Marcella M Johnson, Kim-Anh Do, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2010
Clinical correlates of NRAS and BRAF mutations in primary human melanomaJulie A Ellerhorst, Victoria R Greene, Suhendan Ekmekcioglu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2008
Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanomaJeffrey E Gershenwald, Robert H I Andtbacka, Victor G Prieto, et al.Annals of Internal Medicine|September 22, 2010
Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer: a randomized trialSaroj Vadhan-Raj, Jonathan Trent, Shreyaskumar Patel, et al.Cancer|September 1, 2005
Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survivalSanjay Gupta, Marcella M Johnson, Ravi Murthy, et al.British Journal of Haematology|November 25, 2003
Circulating CD20 and CD52 in patients with non-Hodgkin's lymphoma or Hodgkin's diseaseFrancis J Giles, Julie M Vose, Kim-Anh Do, et al.Cancer|August 27, 2014
Randomized phase 2 study of bone-targeted therapy containing strontium-89 in advanced castrate-sensitive prostate cancerMehmet Asim Bilen, Marcella M Johnson, Paul Mathew, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 19, 2008
Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonatesAna O Hoff, Béla B Toth, Kadri Altundag, et al.Pageof 6